Quarterly report pursuant to Section 13 or 15(d)

Derivative Liabilities (Details)

v3.22.2
Derivative Liabilities (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 12, 2021
Nov. 06, 2020
Jul. 29, 2021
Jun. 30, 2022
Jun. 30, 2022
Feb. 23, 2021
Public SPAC Warrants [Member]            
Derivative Liabilities (Details) [Line Items]            
Warrant, description         Each Public SPAC Warrant entitles the holder to purchase one-half of one share of the Company’s common stock at an exercise price of $5.75 per half share ($11.50 per whole share) until November 6, 2025, subject to adjustment. No fractional shares will be issued upon exercise of the Public SPAC Warrants. Management has determined that the Public SPAC Warrants contain a tender offer provision which could result in the Public SPAC Warrants settling for the tender offer consideration (including potentially cash) in a transaction that didn’t result in a change-in-control. This feature results in the Public SPAC Warrants being precluded from equity classification. Accordingly, the Public SPAC Warrants are classified as liabilities measured at fair value, with changes in fair value each period reported in earnings  
Revalued warrant       $ 1,838,850 $ 1,838,850  
Fair value of the derivative liabilities       4,357,350 6,210,000  
PIPE Warrants [Member]            
Derivative Liabilities (Details) [Line Items]            
Revalued warrant       621,600 621,600  
Fair value of the derivative liabilities       2,849,900 $ 5,894,700  
Purchase of shares of common stock (in Shares)           2,564,000
Exercise price per share (in Dollars per share)           $ 5
Fair value of PIPE warrants           $ 7,294,836
Initial Public Offering [Member] | Public SPAC Warrants [Member]            
Derivative Liabilities (Details) [Line Items]            
Aggregate amount (in Shares)         11,500,000  
Private SPAC Warrants [Member]            
Derivative Liabilities (Details) [Line Items]            
Aggregate amount (in Shares)         502,500  
Warrant, description         Each Private SPAC Warrant entitles the holder to purchase one-half of one share of the Company’s common stock at an exercise price of $5.75 per half share ($11.50 per whole share) until November 6, 2025, subject to adjustment. No fractional shares will be issued upon exercise of the Private SPAC Warrants. Management has determined that the Private SPAC Warrants contain a tender offer provision which could result in the Private SPAC Warrants settling for the tender offer consideration (including potentially cash) in a transaction that didn’t result in a change-in-control. This feature (amongst others) results in the Private SPAC Warrants being precluded from equity classification.  
Revalued warrant       30,150 $ 30,150  
Fair value of the derivative liabilities       185,925 437,175  
Alpha Warrant [Member]            
Derivative Liabilities (Details) [Line Items]            
Revalued warrant       1,720 1,720  
Fair value of the derivative liabilities       18,311 41,841  
Fair value of PIPE warrants       95,677 95,677  
Purchase of aggregate shares (in Shares)     25,000      
Exercise price per share (in Dollars per share)     $ 7.07      
Beneficial ownership     4.99%      
AGP Warrant [Member]            
Derivative Liabilities (Details) [Line Items]            
Revalued warrant       10,395 10,395  
Fair value of the derivative liabilities       $ 76,052 $ 133,936  
Exercise price per share (in Dollars per share)   $ 5.28        
Purchase of aggregate shares (in Shares) 63,658 63,658        
Exercise price per share (in Dollars per share) $ 5.28          
Beneficial ownership 4.99%